COMP <GO>
BME vs NXP // EV/EBITDA & P/E VALUATION
Blackrock Health Sciences Trust (NYSE) VS. Nuveen Select Tax Free Income Portfolio (NYSE) • 15-METRIC TALLY: BME 1
— NXP 1
■ METRIC PARITY
LAST: $46.74 (+1.70%) • MKT CAP: $623.2M
valuation
—
LAST: $13.44 (+1.21%) • MKT CAP: $629.0M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BME VS. NXP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BME | NXP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.4 | 55.3 | +13.11 | BME | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $623.2M | $629.0M | -$5.8M | NXP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BME REV | NXP REV | BME GROSS % | NXP GROSS % | BME FCF | NXP FCF |
|---|---|---|---|---|---|---|
| INSPECT INDIVIDUAL XBRL MODELS AT BME FA <GO> AND NXP FA <GO>. | ||||||
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BME // BETA —
NXP // BETA —